Independent fund research. Built on SEC filings.

How we research funds

ETF · Corporate Bond · Fidelity

IBD Expense Ratio & Fees

Ticker IBD · Since 2017-07-10 · · Holdings as of May 31, 2026

Expense ratio
0.41%$41/yr per $10k
5-yr return
+1.0%annualized
1-yr return
+7.1%as of Dec 2025
Net assets
$466.8Mall share classes
Holdings
252

Bottom line

What is IBD's expense ratio?

IBD's expense ratio is 0.41%, or about $41 a year on every $10,000 invested. That is more expensive than 54% of corporate bond funds we track (median 0.38%).

Updated Mar 26, 2026

IBD fee table

Net expense ratio0.41%
Gross expense ratio0.41%
Management fee0.3%
12b-1 (distribution) fee0%
Other expenses0.11%
Max front-end sales loadNone (ETF)

Source: Fund prospectus fee table, filed Mar 26, 2026

What IBD costs in dollars

The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:

1 year3 years5 years10 years
IBD$42$132$230$518

Source: Fund prospectus expense example

The long-run cost of fees

On $100,000 growing at 6% a year for 20 years, a 0.41% expense ratio costs roughly $23,900 in lost growth, versus about $22,200 for the median corporate bond fund (0.38%).